Student Well-Being

Firm Moves Closer To Brain-Imaging Test for ADHD

By Darcia Harris Bowman — March 28, 2001 2 min read
  • Save to favorites
  • Print

A Boston company is nearing the final phase of testing a diagnostic drug that could offer health-care providers a long-awaited medical test for attention deficit hyperactivity disorder.

Boston Life Sciences Inc. announced this month that its product Altropane was successful in identifying adults who had been clinically diagnosed with long- standing ADHD by mapping the level of certain chemicals in their brain.

ADHD is the most commonly diagnosed behavioral disorder in American children, affecting an estimated 2 million school-age youngsters, according to the National Institutes of Health. Characterized by hyperactivity, short attention spans, and impulsivity, the condition often interferes with a child’s education.

No biological test for diagnosing ADHD is currently available, a situation that some experts contend has led to the misdiagnosis and unnecessary medication of many children. Currently, psychiatrists often rely heavily on reports from parents and educators about children’s behavior in making a diagnosis.

Researchers working on the development of Altropane say their study has shown abnormally high levels of the neurotransmitter dopamine in the brains of people with ADHD, which means a medical diagnosis may not be far away.

“Because of the national controversy presently surrounding the confusion and inconsistencies in the clinical diagnosis of ADHD, and the growing concern over the abuse of stimulant medications by schoolchildren, we believe that the need for an objective, biologically based diagnosis for ADHD has never been greater, nor more urgent for society,” Marc Lanser, Boston Life Science’s chief scientific officer, said in a written statement.

Under guidelines set by the U.S. Food and Drug Administration, the company conducted the first test of its imaging product in 1999 on 10 adult volunteers, six with ADHD, and increased the number of test subjects to 40 for the second phase. The results of the first study were published in The Lancet, a London-based journal of medicine.

The third and final trial of Altropane is to begin this summer with 100 adult test subjects.

Once the testing is wrapped up, Boston Life Sciences will apply to the FDA for fast-track approval to market the product, said Maria Zapf, the company’s manager of corporate affairs.

“Hopefully, this kind of product will quell a little of the controversy over whether ADHD is an actual disorder,” Ms. Zapf said.


Coverage of research is underwritten in part by a grant from the Spencer Foundation.

Related Tags:

A version of this article appeared in the March 28, 2001 edition of Education Week as Firm Moves Closer To Brain-Imaging Test for ADHD

Events

Curriculum Webinar Computer Science Education Movement Gathers Momentum. How Should Schools React?
Discover how schools can expand opportunities for students to study computer science education.
School & District Management Webinar Fostering Student Well-Being with Programs That Work
Protecting student well-being has never been more important. Join this webinar to learn how to ensure your programs yield the best outcomes.
Reading & Literacy Webinar 'Science of Reading': What Are the Components?
Learn how to adopt a “science of reading” approach to early literacy to effectively build students’ vocabulary and content knowledge.

EdWeek Top School Jobs

Teacher Jobs
Search over ten thousand teaching jobs nationwide — elementary, middle, high school and more.
View Jobs
Principal Jobs
Find hundreds of jobs for principals, assistant principals, and other school leadership roles.
View Jobs
Administrator Jobs
Over a thousand district-level jobs: superintendents, directors, more.
View Jobs
Support Staff Jobs
Search thousands of jobs, from paraprofessionals to counselors and more.
View Jobs

Read Next

Student Well-Being Opinion ‘The Timing Is Critical’: How Schools Can Help Refugee Students
Two clinical psychologists suggest several low-cost and effective interventions to help welcome refugee and immigrant families.
Jeffrey P. Winer & Luna A. Mulder
5 min read
Conceptual illustration of a garden growing from adversity
DigitalVision Vectors/Getty
Student Well-Being Half of School Nurses Report Being Harassed, Threatened
The past few years have been tough for school nurses for a few different reasons.
2 min read
Missy Gendron RN, Lewiston High School nurse, unpacks pooled COVID-19 testing materials on Tuesday, Sept. 21, 2021, at Lewiston High School in Lewiston, Maine. Gendron is going to be doing a walk through with staff next week. Classroom pooled testing is planned for the week following. Consent for COVID-19 pooled testing is being collected from parents now.
Missy Gendron, a nurse at Lewiston High School in Maine, unpacks COVID-19 testing materials in September 2021.
Andree Kehn/Sun Journal via AP
Student Well-Being School Sports Participation Drops, Raising Concern About 'Physical Learning Loss'
But interest in e-sports and inclusive teams is rising.
5 min read
The Michigan City High School Girls Varsity Basketball team hosted a Future Wolves basketball camp for elementary and middle school girls on Saturday, March 5, 2022 at the high school.
The varsity girls basketball team at Michigan City High School in Michigan City, Ind., hosted a basketball camp for elementary and middle school girls last spring.
Kelley Smith/The News Dispatch via AP
Student Well-Being Biden's National Strategy on Hunger: What It Means for Schools
The administration seeks more access to free school meals and nutritious foods. But a universal free meals bill is stalled in Congress.
4 min read
President Joe Biden speaks during the White House Conference on Hunger, Nutrition, and Health, at the Ronald Reagan Building, Wednesday, Sept. 28, 2022, in Washington.
President Joe Biden speaks during the White House Conference on Hunger, Nutrition, and Health in Washington on Sept. 28.
Evan Vucci/AP